p.103 抽出テキスト

Medium Safety Committee guidelines. Eur Radiol 2018;28:2845–55. https://doi.org/10. 1007/s00330-017-5246-5 390. Bittencourt MS, Hulten EA, Murthy VL, Cheezum M, Rochitte CE, Carli MFD, et al. Clinical outcomes after evaluation of stable chest pain by coronary computed tomographic angiography versus usual care: a meta-analysis. Circ Cardiovasc Imaging 2016;9: e004419. https://doi.org/10.1161/CIRCIMAGING.115.004419 391. Reis JF, Ramos RB, Marques H, Daniel PM, Aguiar SR, Morais LA, et al. Cardiac computed tomographic angiography after abnormal ischemia test as a gatekeeper to invasive coronary angiography. Int J Cardiovasc Imaging 2022;38:883–93. https://doi.org/10. 1007/s10554-021-02426-6 392. Maaniitty T, Stenstrom I, Bax JJ, Uusitalo V, Ukkonen H, Kajander S, et al. Prognostic value of coronary CT angiography with selective PET perfusion imaging in coronary artery disease. JACC Cardiovasc Imaging 2017;10:1361–70. https://doi.org/10.1016/j. jcmg.2016.10.025 393. Pezel T, Hovasse T, Lefevre T, Sanguineti F, Unterseeh T, Champagne S, et al. Prognostic value of stress CMR in symptomatic patients with coronary stenosis on CCTA. JACC Cardiovasc Imaging 2022;15:1408–22. https://doi.org/10.1016/j.jcmg. 2022.03.008 394. Winther S, Andersen IT, Gormsen LC, Steffensen FH, Nielsen LH, Grove EL, et al. Prognostic value of myocardial perfusion imaging after first-line coronary computed tomography angiography: a multi-center cohort study. J Cardiovasc Comput Tomogr 2022;16:34–40. https://doi.org/10.1016/j.jcct.2021.08.001 395. Min JK, Leipsic J, Pencina MJ, Berman DS, Koo B-K, van Mieghem C, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 2012;308: 1237–45. https://doi.org/10.1001/2012.jama.11274 396. Douglas PS, De Bruyne B, Pontone G, Patel MR, Norgaard BL, Byrne RA, et al. 1-Year outcomes of FFRCT-guided care in patients with suspected coronary disease: the PLATFORM study. J Am Coll Cardiol 2016;68:435–45. https://doi.org/10.1016/j.jacc. 2016.05.057 397. Fairbairn TA, Nieman K, Akasaka T, Nørgaard BL, Berman DS, Raff G, et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE registry. Eur Heart J 2018;39:3701–11. https://doi.org/10.1093/eurheartj/ehy530 398. Andreini D, Modolo R, Katagiri Y, Mushtaq S, Sonck J, Collet C, et al. Impact of fractional flow reserve derived from coronary computed tomography angiography on heart team treatment decision-making in patients with multivessel coronary artery disease: insights from the SYNTAX III REVOLUTION trial. Circ Cardiovasc Interv 2019;12: e007607. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007607 399. Patel MR, Norgaard BL, Fairbairn TA, Nieman K, Akasaka T, Berman DS, et al. 1-year impact on medical practice and clinical outcomes of FFR(CT): the ADVANCE registry. JACC Cardiovasc Imaging 2020;13:97–105. https://doi.org/10.1016/j.jcmg.2019.03.003 400. Riedl KA, Jensen JM, Ko BS, Leipsic J, Grove EL, Mathiassen ON, et al. Coronary CT angiography derived FFR in patients with left main disease. Int J Cardiovasc Imaging 2021;37:3299–308. https://doi.org/10.1007/s10554-021-02371-4 401. Nørgaard BL, Gaur S, Fairbairn TA, Douglas PS, Jensen JM, Patel MR, et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. Heart 2022;108:194–202. https://doi.org/10. 1136/heartjnl-2021-319773 402. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 2018;391:31–40. https://doi.org/10.1016/S0140-6736(17)32714-9 403. Foley M, Rajkumar CA, Shun-Shin M, Ganesananthan S, Seligman H, Howard J, et al. Achieving optimal medical therapy: insights from the ORBITA trial. J Am Heart Assoc 2021;10:e017381. https://doi.org/10.1161/JAHA.120.017381 404. Mesnier J, Ducrocq G, Danchin N, Ferrari R, Ford I, Tardif J-C, et al. International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study. Circulation 2021;144:512–23. https://doi.org/10.1161/ CIRCULATIONAHA.121.054567 405. Task Force Members; Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC Guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003. https://doi.org/10.1093/ eurheartj/eht296 406. Rapsomaniki E, Shah A, Perel P, Denaxas S, George J, Nicholas O, et al. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J 2014;35:844–52. https://doi.org/10.1093/eurheartj/ eht533 407. Barbero U, D’Ascenzo F, Nijhoff F, Moretti C, Biondi-Zoccai G, Mennuni M, et al. Assessing risk in patients with stable coronary disease: when should we intensify care and follow-up? Results from a meta-analysis of observational studies of the COURAGE and FAME era. Scientifica (Cairo) 2016;2016:3769152. https://doi.org/10. 1155/2016/3769152 408. Sorbets E, Fox KM, Elbez Y, Danchin N, Dorian P, Ferrari R, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J 2020;41:347–56. https://doi.org/10.1093/eurheartj/ehz660 409. Liu Y, Song J, Wang W, Zhang K, Qi Y, Yang J, et al. Association of ejection fraction with mortality and cardiovascular events in patients with coronary artery disease. ESC Heart Fail 2022;9:3461–8. https://doi.org/10.1002/ehf2.14063 410. Thuijs D, Milojevic M, Stone GW, Puskas JD, Serruys PW, Sabik JF, et al. Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial. Eur J Heart Fail 2020;22:871–9. https://doi.org/10.1002/ejhf.1681 411. Abidov A, Rozanski A, Hachamovitch R, Hayes SW, Aboul-Enein F, Cohen I, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 2005;353:1889–98. https://doi.org/10.1056/NEJMoa042741 412. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793–801. https://doi.org/10.1056/NEJMoa011858 413. Sipilä K, Tikkakoski A, Alanko S, Haarala A, Hernesniemi J, Lyytikäinen L-P, et al. Combination of low blood pressure response, low exercise capacity and slow heart rate recovery during an exercise test significantly increases mortality risk. Ann Med 2019;51:390–6. https://doi.org/10.1080/07853890.2019.1684550 414. Salokari E, Laukkanen JA, Lehtimaki T, Kurl S, Kunutsor S, Zaccardi F, et al. The Duke treadmill score with bicycle ergometer: exercise capacity is the most important predictor of cardiovascular mortality. Eur J Prev Cardiol 2019;26:199–207. https://doi. org/10.1177/2047487318804618 415. Williams MC, Kwiecinski J, Doris M, McElhinney P, D’Souza MS, Cadet S, et al. Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART). Circulation 2020;141:1452–62. https://doi.org/10.1161/CIRCULATIONAHA.119.044720 416. Mortensen MB, Dzaye O, Steffensen FH, Bøtker HE, Jensen JM, Rønnow Sand NP, et al. Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis. J Am Coll Cardiol 2020;76:2803–13. https://doi.org/10.1016/j.jacc.2020. 10.021 417. van Rosendael AR, Bax AM, Smit JM, van den Hoogen IJ, Ma X, Al’Aref S, et al. Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry. Eur Heart J Cardiovasc Imaging 2020;21: 479–88. https://doi.org/10.1093/ehjci/jez322 418. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831–7. 419. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LEJ, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012–24. https://doi.org/10.1093/ eurheartj/ehq500 420. Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 2013;62:826–38. https://doi.org/10.1016/j.jacc.2013.03.080 421. Patel KK, Spertus JA, Chan PS, Sperry BW, Thompson RC, Al Badarin F, et al. Extent of myocardial ischemia on positron emission tomography and survival benefit with early revascularization. J Am Coll Cardiol 2019;74:1645–54. https://doi.org/10.1016/j.jacc. 2019.07.055 422. Azadani PN, Miller RJH, Sharir T, Diniz MA, Hu L-H, Otaki Y, et al. Impact of early revascularization on major adverse cardiovascular events in relation to automatically quantified ischemia. JACC Cardiovasc Imaging 2021;14:644–53. https://doi.org/10. 1016/j.jcmg.2020.05.039 423. Sharir T, Hollander I, Hemo B, Tsamir J, Yefremov N, Bojko A, et al. Survival benefit of coronary revascularization after myocardial perfusion SPECT: the role of ischemia. J Nucl Cardiol 2021;28:1676–87. https://doi.org/10.1007/s12350-019-01932-4 424. Ciampi Q, Zagatina A, Cortigiani L, Wierzbowska-Drabik K, Kasprzak JD, Haberka M, et al. Prognostic value of stress echocardiography assessed by the ABCDE protocol. Eur Heart J 2021;42:3869–78. https://doi.org/10.1093/eurheartj/ehab493 425. Picano E, Pierard L, Peteiro J, Djordjevic-Dikic A, Sade LE, Cortigiani L, et al. The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European Association of Cardiovascular Imaging of the ESC. Eur Heart J Cardiovasc Imaging 2023;25:e65–90. https://doi.org/10.1093/ehjci/jead250 426. Mancini GBJ, Hartigan PM, Shaw LJ, Berman DS, Hayes SW, Bates ER, et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv 2014;7:195–201. https://doi.org/10.1016/j.jcin.2013.10.017 427. Weintraub WS, Hartigan PM, Mancini GBJ, Teo KK, Maron DJ, Spertus JA, et al. Effect of coronary anatomy and myocardial ischemia on long-term survival in patients with stable ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019;12:e005079. https://doi.org/10.1161/circoutcomes.118.005079

ESC Guidelines                                                                                                                                                                                          3517

Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026